New Key Statistics Module, Z-Score and F-Score
NAS:DMAC Key Ratios
Market Cap $ M | 120.35 |
Enterprise Value $ M | 74.21 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.60 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.56 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 7.20 |
5-y EBITDA Growth Rate % | 6.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.45 |
EV-to-EBITDA | -3.46 |
PEG | -- |
Shares Outstanding M | 37.96 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 18.14 |
Current Ratio | 18.14 |
ROA % (ttm) | -37.94 |
ROE % (ttm) | -40.16 |
ROIC % (ttm) | -294.42 |
Dividend Yield % | -- |
Altman Z-Score | -- |
DMAC Number of Guru Trades
DMAC Volume of Guru Trades
Gurus Latest Trades with NAS:DMAC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DMAC is held by these investors
Total 1
DiaMedica Therapeutics Inc Insider Transactions
No Available Data
News about NAS:DMAC
Total 0- 1